Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hancock

Showing results (491-500 of 557) with videos related to

Pageof 56
Sort By:
Journal of the American Veterinary Medical Association|May 1, 1983
Cause and pathogenesis of middle ear infection in young feedlot cattleR Jensen, L R Maki, L H Lauerman, et al.
British Journal of Cancer|January 15, 2016
A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomasMilan Radovich, Jeffrey P Solzak, Bradley A Hancock, et al.
Journal of Medicinal Chemistry|January 7, 2005
4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attentionMarlon Cowart, Ramin Faghih, Michael P Curtis, et al.
Molecular Cancer Therapeutics|February 13, 2015
The IGF-Trap: Novel Inhibitor of Carcinoma Growth and MetastasisNi Wang, Roni F Rayes, Seyyed Mehdy Elahi, et al.
ACS Chemical Neuroscience|October 28, 2017
Dendritic Polyglycerol Sulfates in the Prevention of Synaptic Loss and Mechanism of Action on GliaDusica Maysinger, Jeff Ji, Alexandre Moquin, et al.
Pharmacology, Biochemistry, and Behavior|August 15, 2002
Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia modelGerard B Fox, Jia Bao Pan, Timothy A Esbenshade, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effectsTimothy A Esbenshade, Kathleen M Krueger, Thomas R Miller, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterizationGerard B Fox, Jia Bao Pan, Richard J Radek, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2002
Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifsRamin Faghih, Wesley Dwight, Larry Black, et al.
Malaria Journal|August 5, 2024
Publisher Correction: Considerations for first field trials of low-threshold gene drive for malaria vector controlJohn B Connolly, Austin Burt, George Christophides, et al.
Pageof 56

Showing results (491-500 of 557) with videos related to

Sort By:
Pageof 56
Journal of the American Veterinary Medical Association|May 1, 1983
Cause and pathogenesis of middle ear infection in young feedlot cattleR Jensen, L R Maki, L H Lauerman, et al.
British Journal of Cancer|January 15, 2016
A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomasMilan Radovich, Jeffrey P Solzak, Bradley A Hancock, et al.
Journal of Medicinal Chemistry|January 7, 2005
4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attentionMarlon Cowart, Ramin Faghih, Michael P Curtis, et al.
Molecular Cancer Therapeutics|February 13, 2015
The IGF-Trap: Novel Inhibitor of Carcinoma Growth and MetastasisNi Wang, Roni F Rayes, Seyyed Mehdy Elahi, et al.
ACS Chemical Neuroscience|October 28, 2017
Dendritic Polyglycerol Sulfates in the Prevention of Synaptic Loss and Mechanism of Action on GliaDusica Maysinger, Jeff Ji, Alexandre Moquin, et al.
Pharmacology, Biochemistry, and Behavior|August 15, 2002
Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia modelGerard B Fox, Jia Bao Pan, Timothy A Esbenshade, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effectsTimothy A Esbenshade, Kathleen M Krueger, Thomas R Miller, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterizationGerard B Fox, Jia Bao Pan, Richard J Radek, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2002
Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifsRamin Faghih, Wesley Dwight, Larry Black, et al.
Malaria Journal|August 5, 2024
Publisher Correction: Considerations for first field trials of low-threshold gene drive for malaria vector controlJohn B Connolly, Austin Burt, George Christophides, et al.
Pageof 56